Mariner’s iShares iBonds Dec 2031 Term Corporate ETF IBDW Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$13.6M Buy
649,578
+43,640
+7% +$922K 0.02% 610
2025
Q4
$12.8M Buy
605,938
+517,680
+587% +$11M 0.02% 592
2025
Q3
$1.87M Buy
88,258
+5,718
+7% +$120K ﹤0.01% 1482
2025
Q2
$1.74M Buy
82,540
+1,763
+2% +$36.4K ﹤0.01% 1435
2025
Q1
$1.68M Buy
80,777
+3,009
+4% +$61.7K ﹤0.01% 1339
2024
Q4
$1.58M Buy
77,768
+4,696
+6% +$97.1K ﹤0.01% 1351
2024
Q3
$1.55M Buy
73,072
+774
+1% +$16.1K ﹤0.01% 1332
2024
Q2
$1.47M Buy
72,298
+12,850
+22% +$259K ﹤0.01% 1275
2024
Q1
$1.22M Buy
59,448
+38,240
+180% +$782K ﹤0.01% 1382
2023
Q4
$440K Buy
+21,208
New +$418K ﹤0.01% 2033

Other funds holding IBDW

Mariner's IBDW Position: Q1 2026 in Review

Mariner increased its iShares iBonds Dec 2031 Term Corporate ETF (IBDW) stake by 7.2% in Q1 2026, buying an estimated $922K and bringing the position to 649,578 shares worth $13.6M. The position accounts for 0.02% of the portfolio, ranked #610.

Mariner first reported a position in IBDW in Q4 2023 and has held it in 10 quarters since. 288 funds tracked by Wall St. Rank hold IBDW as of Q1 2026.

  • Mariner held 649,578 shares of iShares iBonds Dec 2031 Term Corporate ETF worth $13.6M as of Q1 2026.
  • Mariner bought 43,640 iShares iBonds Dec 2031 Term Corporate ETF shares in Q1 2026, an estimated $922K.
  • iShares iBonds Dec 2031 Term Corporate ETF made up 0.02% of Mariner's portfolio in Q1 2026, its #610 holding.
  • Mariner first reported a position in iShares iBonds Dec 2031 Term Corporate ETF in Q4 2023 and has held it in 10 quarters since.
  • 288 funds tracked by Wall St. Rank held iShares iBonds Dec 2031 Term Corporate ETF as of Q1 2026.

Based on Mariner's 13F filing for Q1 2026, filed 13 May 2026.